In Russian pharmacies there is a shortage of anti-gout drugs, colchicine and colchicum, which make up about 17% of the profile market, Kommersant writes. According to the DSM group, there are no other registered drugs with a similar active ingredient in Israel. At the same time, Rozderbandzor stated that from the beginning of 2026, about 127 thousand packages of these drugs were put into circulation, their balances are about 32 thousand pieces, and there were no complaints about shortages from the patients.

In Russian pharmacies there is a shortage of anti-gout drugs, colchicine and colchicum, which make up about 17% of the profile market, Kommersant writes. According to the DSM group, there are no other registered drugs with a similar active ingredient in Israel. At the same time, Rozderbandzor stated that from the beginning of 2026, about 127 thousand packages of these drugs were put into circulation, their balances are about 32 thousand pieces, and there were no complaints about shortages from the patients.